Dec. 31 Deadline Looms For Dozens Of Unlicensed Medical Marijuana Firms In Michigan

Up to six dozen unlicensed medical cannabis businesses in Michigan must close at least temporarily by Dec. 31 or risk not receiving a permanent license under a new, stricter regulatory system, state officials indicated Friday.

Regulators noted in a news release that Michigan Court of Claims Judge Stephen Borrello had dismissed the last pending court case challenging the state’s deadline.

State officials previously had agreed that businesses that had applied for a license under the new regulatory system by Feb. 15 and had local approval could temporarily operate until Dec. 31.

David Harns, spokesman for the Michigan Department of Licensing and Regulatory Affairs, wouldn’t say if the state would actively enforce the Dec. 31 deadline.

He would say that “it is very important for temporarily operating applicants to understand that any operation after Monday may be considered an impediment to licensure.”

Harns wrote in an email that up to 72 businesses might be affected, “though we don’t truly know if all 72 are currently open.”

Michigan regulators have approved 99 licenses under the new system, including 52 dispensaries. The next meeting to consider license applications is Jan. 16.

Advocates had been concerned about possible supply and access issues during the transition to the new, trimmed-down system. The state once had several hundred dispensaries, although that number was cut roughly in half earlier this year.

To ease supply concerns, Michigan regulators are allowing licensed MMJ businesses to supplement their supplies by buying products from registered caregivers through Dec. 31 and selling those products until Jan. 31, 2019.

Original Article Source: https://mjbizdaily.com/unlicensed-medical-marijuana-businesses-michigan-face-dec-31-deadline/

Comments

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Norma Pence

Search This Blog